Literature DB >> 15236681

Utilization of newly developed immobilized enzyme reactors for preparation and study of immunoglobulin G fragments.

Lucie Korecká1, Zuzana Bílková, Michal Holèapek, Josef Královský, Milan Benes, Jiøí Lenfeld, Nicolas Minc, Roxana Cecal, Jean-Louis Viovy, Michael Przybylski.   

Abstract

The newly developed immobilized enzyme reactors (IMERs) with proteolytic enzymes chymotrypsin, trypsin or papain were used for specific fragmentation of high molecular-mass and heterogeneous glycoproteins immunoglobulin G (IgG) and crystallizable fragment of IgG (Fc). The efficiency of splitting or digestion were controlled by RP-HPLC. The specificity of digestion by trypsin reactor was controlled by MS. IMERs (trypsin immobilized on magnetic microparticles focused in a channel of magnetically active microfluidic device) was used for digestion of the whole IgG molecule. The sufficient conditions for IgG digestion in microfluidic device (flow rate, ratio S:E, pH, temperature) were optimized. It was confirmed that the combination of IMERs with microfluidic device enables efficient digestion of highly heterogeneous glycoproteins such as IgG in extremely short time and minimal reaction volume.

Mesh:

Substances:

Year:  2004        PMID: 15236681     DOI: 10.1016/j.jchromb.2004.04.035

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Protein digestion and phosphopeptide enrichment on a glass microchip.

Authors:  Guihua Eileen Yue; Michael G Roper; Catherine Balchunas; Abigail Pulsipher; Joshua J Coon; Jeffery Shabanowitz; Donald F Hunt; James P Landers; Jerome P Ferrance
Journal:  Anal Chim Acta       Date:  2005-12-20       Impact factor: 6.558

2.  A magnetically active microfluidic device for chemiluminescence bioassays.

Authors:  Yi Zheng; Shulin Zhao; Yi-Ming Liu
Journal:  Analyst       Date:  2011-06-07       Impact factor: 4.616

Review 3.  Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.

Authors:  Kerry M Wooding; Wenjing Peng; Yehia Mechref
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.